Ignite Creation Date:
2025-12-24 @ 1:59 PM
Ignite Modification Date:
2026-01-01 @ 9:08 AM
Study NCT ID:
NCT00405795
Status:
COMPLETED
Last Update Posted:
2008-07-04
First Post:
2006-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Envision® Surface Evaluation
Sponsor:
Hill-Rom
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MR-2005-083
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Gordon MacFarlane, PhD, Director Clinical Research
Old Organization:
Hill-Rom